ALEXANDRIA REAL ESTATE EQUITIES, INC.
ARE| Fund | Shares Held | Position Value | Action (latest Q) |
|---|---|---|---|
| Citadel Ken Griffin | 1.74M | $85.07M | NEW |
| D.E. Shaw David Shaw | 591K | $28.92M | NEW |
| Marshall Wace | 200K | $9.79M | NEW |
| Politician | Date | Type | Amount |
|---|---|---|---|
| Gilbert Cisneros D-CA | 2026-04-14 | purchase | $1k – $15k |
| Lois Frankel D-FL | 2023-09-08 | sale | $1k – $15k |
| Daniel Goldman NY | 2023-07-12 | sale | $15k – $50k |
| Lois Frankel D-FL | 2023-05-16 | purchase | $1k – $15k |
| Thomas R Carper | 2020-11-20 | purchase | $1k – $15k |
| Thomas R Carper | 2020-08-21 | partial sale | $1k – $15k |
| Dwight Evans D-PA | 2020-07-27 | purchase | $1k – $15k |
| Thomas R Carper | 2020-04-02 | purchase | $1k – $15k |
Alexandria Real Estate Equities, Inc. is an S&P 500 company and a leading real estate investment trust (REIT) focused exclusively on the life science sector. It owns, operates, and develops collaborative Megacampus ecosystems designed to foster innovation and productivity for life science tenants. These properties are strategically located in premier innovation clusters across North America, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. The company specializes in high-quality Class A/A+ properties that support research, development, and production activities for biotechnology, pharmaceutical, and medical technology firms. Alexandria Real Estate Equities, Inc. also provides strategic venture capital to promising life science companies, enhancing its role in the ecosystem. Founded in 1994 and headquartered in Pasadena, California, it maintains an investment-grade balance sheet and emphasizes long-term stability through diverse, high-occupancy tenant relationships and mission-driven real estate solutions tailored to the dynamic needs of the life science industry.
Earnings calendar coming soon. Subscribe to get notified when ARE reports next.
Get earnings alerts →